Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000918:Antibody Specificity; D001402:B-Lymphocytes / Q000276:immunology*; D002460:Cell Line; D002470:Cell Survival; D003602:Cytotoxicity, Immunologic; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D046911:Macromolecular Substances; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology*; D012276:Ricin / Q000276:immunology*
D000912:Antibodies, Neoplasm; D004338:Drug Combinations; D046911:Macromolecular Substances; D012276:Ricin